While this study focused on the post-stroke alterations to MEVs, and the involvement of CD14 and MHC-II in the response to ischemic stress, future studies should harness recent advancements in transcriptomics to identify disease-specific candidate MEV markers. The gene discussed is CD14; the disease is Stroke.